Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04567849
Other study ID # 2020-0849
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 16, 2021
Est. completion date June 15, 2023

Study information

Verified date July 2023
Source Geisinger Clinic
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In the present study, patients will be sent a message shortly after completing a medical procedure that informs or reminds them that they can reach out to Geisinger, and how to do it, if they have any medical issues or concerns. Researchers will assess if such messages make patients more likely to contact Geisinger with post-procedure medical concerns and decrease emergency department utilization.


Description:

Decreasing emergency department (ED) over-utilization is a priority for healthcare systems across the country. Patients uncertain about a medical issue routinely end up in the ED when less costly and time-consuming alternatives could have addressed their concern. If patients reach out to healthcare facilities rather than heading directly to the ED, they can often be directed toward resources better suited to their concerns than the ED. Geisinger is thus working to encourage patients to contact healthcare providers if any concerns arise and patients are uncertain about where to go for care. Patients who have recently had a medical procedure may be particularly valuable to encourage, as they routinely have concerns related to the procedure and discharge can serve as a useful touch-point to remind the patient where they can go for questions or concerns. In the present study, patients will be sent a patient portal message shortly after completing any Women's Health medical procedure. The message will inform or remind patients how they can reach Geisinger if they have any medical issues or concerns. The purpose of this study is to assess if such messages make patients more likely to contact Geisinger with medical concerns and, in turn, decrease unnecessary ED utilization. This study will A/B test 2 messages, encouraging patients to either call their recent provider directly or to call a tele-nurse hotline, and will assess if these messages perform better than a control group that will not be sent any such message. Generalized linear models will examine the primary study outcomes as a function of the study arms (between-subjects).


Recruitment information / eligibility

Status Completed
Enrollment 11546
Est. completion date June 15, 2023
Est. primary completion date June 15, 2023
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Patient had a procedure in Women's Health within the study period (including both surgical and in-office procedures as well as baby delivery) - Patient is enrolled in myGeisinger, Geisinger's patient portal Exclusion Criteria: - If procedure was labor that resulted in fetal demise or stillborn.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
message
patient portal message
provider
nudging calling the patient's provider
tele-nurse
nudging calling the tele-nurse

Locations

Country Name City State
United States Geisinger Danville Pennsylvania

Sponsors (1)

Lead Sponsor Collaborator
Geisinger Clinic

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Phone calls Proportion of patients who call the tele-nurse or their provider within 30 days of their appointment 18 months or as long as it takes to reach N=17,300, whichever occurs first
Primary ED utilization Proportion of patients who visit the ED within 30 days of their appointment 18 months or as long as it takes to reach N=17,300, whichever occurs first
Secondary Phone calls Proportion of patients who call the tele-nurse or their provider within 30 days of their appointment 12 months
Secondary ED utilization Proportion of patients who visit the ED within 30 days of their appointment 12 months
Secondary Phone calls - surgical patients only Proportion of patients who call the tele-nurse or their provider within 30 days of their appointment 18 months or as long as it takes to reach N=17,300, whichever occurs first
Secondary ED utilization - surgical patients only Proportion of patients who visit the ED within 30 days of their appointment 18 months or as long as it takes to reach N=17,300, whichever occurs first
Secondary Phone calls - surgical patients only Proportion of patients who call the tele-nurse or their provider within 30 days of their appointment 12 months
Secondary ED utilization - surgical patients only Proportion of patients who visit the ED within 30 days of their appointment 12 months
See also
  Status Clinical Trial Phase
Completed NCT01635660 - Out-of-Hospital Randomized Comparison of Video-assisted Endotracheal Intubation N/A
Completed NCT00249171 - A Study of Risperidone in Combination With Lorazepam Compared With Standard Therapy for Emergency Treatment of Schizophrenic Patients Phase 4
Completed NCT05272267 - Transforming ED Throughput With AI-Driven Clinical Decision Support System N/A